Cargando…

Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer

Although the oncolytic parvovirus H-1PV has entered clinical trials, predicting therapeutic success remains challenging. We investigated whether the antiviral state in tumor cells determines the parvoviral oncolytic efficacy. The interferon/interferon-stimulated genes (IFN/ISG)-circuit and its major...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neulinger-Muñoz, Matthias, Schaack, Dominik, Grekova, Svetlana P., Bauer, Andrea S., Giese, Thomas, Salg, Gabriel A., Espinet, Elisa, Leuchs, Barbara, Heller, Anette, Nüesch, Jürg P. F., Schenk, Miriam, Volkmar, Michael, Giese, Nathalia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228339/ https://www.ncbi.nlm.nih.gov/pubmed/34071585 http://dx.doi.org/10.3390/v13061019

Ejemplares similares

TLR-9 Contributes to the Antiviral Innate Immune Sensing of Rodent Parvoviruses MVMp and H-1PV by Normal Human Immune Cells
por: Raykov, Zahari, et al.
Publicado: (2013)

Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro
por: Geiss, Carsten, et al.
Publicado: (2017)

Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas
por: Li, Junwei, et al.
Publicado: (2013)

Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients
por: Angelova, Assia L., et al.
Publicado: (2015)

Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1
por: Moehler, Markus, et al.
Publicado: (2011)

A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles
por: Leuchs, Barbara, et al.
Publicado: (2017)

Oncolytic effects of parvovirus H-1 in medulloblastoma are associated with repression of master regulators of early neurogenesis
por: Lacroix, Jeannine, et al.
Publicado: (2014)

The emerging field of pancreatic tissue engineering: A systematic review and evidence map of scaffold materials and scaffolding techniques for insulin-secreting cells
por: Salg, Gabriel Alexander, et al.
Publicado: (2019)

Toward 3D-bioprinting of an endocrine pancreas: A building-block concept for bioartificial insulin-secreting tissue
por: Salg, Gabriel A, et al.
Publicado: (2022)

Parvoviruses-tools to fine-tune anticancer immune responses
por: Grekova, Svitlana P., et al.
Publicado: (2012)

Vesicular Egress of Non-Enveloped Lytic Parvoviruses Depends on Gelsolin Functioning
por: Bär, Séverine, et al.
Publicado: (2008)

Vesicular Transport of Progeny Parvovirus Particles through ER and Golgi Regulates Maturation and Cytolysis
por: Bär, Séverine, et al.
Publicado: (2013)

Oncolytic parvoviruses: from basic virology to clinical applications
por: Marchini, Antonio, et al.
Publicado: (2015)

Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo
por: Lacroix, Jeannine, et al.
Publicado: (2018)

Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1
por: Moehler, Markus, et al.
Publicado: (2014)

PKCη/Rdx-driven Phosphorylation of PDK1: A Novel Mechanism Promoting Cancer Cell Survival and Permissiveness for Parvovirus-induced Lysis
por: Bär, Séverine, et al.
Publicado: (2015)

Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer
por: Throm, Verena M., et al.
Publicado: (2018)

Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells
por: Ferreira, Tiago, et al.
Publicado: (2022)

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
por: Geletneky, Karsten, et al.
Publicado: (2017)

[Shutdown]
por: CERN Press Office. Geneva
Publicado: (1980)

Generation and Validation of Monoclonal Antibodies Suitable for Detecting and Monitoring Parvovirus Infections
por: Tessmer, Claudia, et al.
Publicado: (2022)

Combination of IAP Antagonists and TNF-α-Armed Oncolytic Viruses Induce Tumor Vascular Shutdown and Tumor Regression
por: Beug, Shawn T., et al.
Publicado: (2018)

Oncolytic H-1 Parvovirus Enters Cancer Cells through Clathrin-Mediated Endocytosis
por: Ferreira, Tiago, et al.
Publicado: (2020)

Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
por: Kulkarni, Amit, et al.
Publicado: (2021)

Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors
por: Keleg, Shereen, et al.
Publicado: (2014)

PS shutdown
Publicado: (1970)

PS shutdown
Publicado: (1972)

Annual shutdown
Publicado: (1974)

Annual shutdown
Publicado: (1973)

Annual shutdown
Publicado: (1975)

Shutdown and after
por: Marmot, Michael
Publicado: (2022)

Molecular Characterization and Pathogenicity of Chicken Parvovirus (ChPV) in Specific Pathogen-Free Chicks Infected Experimentally
por: N. Nuñez, Luis Fabian, et al.
Publicado: (2020)

Molecular Characterization of Parvovirus Strain GX-Tu-PV-1, Isolated from a Guangxi Turkey
por: Zhang, Yanfang, et al.
Publicado: (2019)

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
por: Angelova, Assia L., et al.
Publicado: (2017)

The interplay between Hebbian and homeostatic synaptic plasticity
por: Vitureira, Nathalia, et al.
Publicado: (2013)

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses
por: Ungerechts, Guy, et al.
Publicado: (2016)

Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia
por: Wang, Weiyi, et al.
Publicado: (2021)

Shutdown Modifications 2008/9 and Future shutdowns: Summary of Session 5
por: Baird, S, et al.
Publicado: (2009)

Deletion of KCNQ2/3 potassium channels from PV+ interneurons leads to homeostatic potentiation of excitatory transmission
por: Soh, Heun, et al.
Publicado: (2018)

Activation of a Helper and Not Regulatory Human CD4+ T Cell Response by Oncolytic H-1 Parvovirus
por: Moralès, Olivier, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9e0t92j3e36jll29ofvpongab0